While mutations affecting most enzymes of the BH4 anabolic pathways are associated with hyperphenylalaninemia (Himmelreich et al., 2021), a loss of function of sepiapterin reductase (SPR), the last enzyme in the de novo synthesis production pathway, does not (Bonafé et al., 2001). This evidence concerns the gene SPR and Hyperphenylalaninemia.